We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

DNA Methylation and the Cancer Epigenome Biological and Translations Implications

Video   Jan 01, 2014

 

About the Speaker

Stephen B. Baylin, M.D., is deputy director of The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and the Virginia and D.K. Ludwig professor of oncology and medicine. He is chief of the Cancer Biology Division and associate director for research of the center.


Abstract

Genome-wide mapping studies are dramatically contributing to remarkable increases in our understanding of epigenetic abnormalities in cancer.  Abnormal DNA methylation, both losses and gains, and key associated chromatin changes may largely affect  distinct  genomic  regions which contain nuclear lamin associated,  late replicating DNA , enriched for  low transcription, developmental, genes  with promoter region, “bivalent” chromatin .  Such chromatin, in embryonic and adult stem cells, is essential for maintenance of the stem cell state.  Furthermore, in multiple tumor types, frequent mutations are being found in genes which control normal epigenomes.  While the phenotypic consequences of these largely remain to be dissected, mutations in the IDH1 and 2 genes, and in the Tet family of proteins which trigger steps for active DNA de-methylation, are now linked to DNA methylation and chromatin alterations associated with abnormal gene silencing.  Importantly, multiple of the above epigenetic abnormalities are being found in cancer-risk states which involve chronic inflammation and attendant increases in reactive oxygen species (ROS).  Finally, all of the above biology has exciting translational implications for the concepts of “epigenetic therapy” for cancer and molecular signatures which can guide such treatments and also be useful for cancer diagnosis and staging.

 
 
 
 

Recommended Videos

Terabases of sequence data in real time

Video

PromethION offers the same real-time, long-read, direct DNA and RNA sequencing technology as MinION and GridION, on a much larger scale.

WATCH NOW

SNP Genotyping on qPCR Platforms: Troubleshooting for Amplification and Cluster Separation

Video

Daniel Tsang provides an overview of genotyping using real-time PCR (qPCR) technology, including challenges and ways to overcome these challenges.

WATCH NOW

Ready for a change of scenery?

Video

Get a new perspective on your sample QC with the Agilent 4150 TapeStation system and open up new horizons. Ideal for handling smaller numbers of samples, the system with ScreenTape assays delivers fast, reliable results within any NGS workflow.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE